Pfizer (Japan)

Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

Yoshiya Tanaka, Makoto Suzuki, Hiroyuki Nakamura et al. · Arthritis Care & Research · 2011 · 295 citations

Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity

Chung‐Ren Lin, Fumimasa Amaya, Lee Barrett et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 249 citations

PAMPA—critical factors for better predictions of absorption

Alex Avdeef, Stefanie Bendels, Lei Di et al. · Journal of Pharmaceutical Sciences · 2007 · 235 citations

Pampa—critical Factors, Medicine, Spectroscopy +4

The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

Jeffrey L. Stock, Katsuhiro Shinjo, John Burkhardt et al. · Journal of Clinical Investigation · 2001 · 235 citations · Full text

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey et al. · Arthritis & Rheumatology · 2017 · 232 citations · Full text